Provided by Tiger Trade Technology Pte. Ltd.

Tema Heart & Health ETF

38.37
-0.3972-1.02%
Volume:4K
Turnover:141.11K
Market Cap:57.17M
PE:- -
High:38.57
Open:38.57
Low:38.37
Close:38.77
52wk High:38.87
52wk Low:29.26
Shares:1.49M
Float Shares:1.49M
Volume Ratio:2.73
T/O Rate:0.25%
Dividend:0.47
Dividend Rate:1.23%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly Targets Ramadan Diabetes Market With New Orforglipron Trial

TIPRANKS
·
Aug 22

Eli Lilly’s Dulaglutide Study Sheds Light on Fasting Risks and Diabetes Care

TIPRANKS
·
Aug 22

Moderna Shares Whipsaw for Third Session on Cancer Vaccine Trial Data

Reuters
·
Aug 21

Moderna, Robinhood, Marvell, Tesla, SpaceX, and More Stocks That Explain Today's Market

Dow Jones
·
Aug 21

Merck's Near-Term Catalysts Create Bull-Bear Debate, RBC Capital Markets Says

MT Newswires Live
·
Aug 21

Merck & Co Inc Stock (MRK) Moved Up by 3.41% on Aug 21: Facts Behind the Movement

TradingKey
·
Aug 21

Jabil Stock Leads 3 Undervalued Cash Flow Picks With AI Data Center Exposure

Simply Wall St.
·
Aug 21

Pharma Stocks Have Rallied. 2 Stocks to Avoid-and 2 to Buy.

Dow Jones
·
Aug 21

William O'Neil Initiates Thermo Fisher Scientific at Buy

MT Newswires Live
·
Aug 21

African Markets - Factors to Watch on Aug 21

Reuters
·
Aug 21

Moderna’s Personalized MRNA Shot Could Reshape the Fight Against Skin Cancer — but It May Also Be Overhyped

Dow Jones
·
Aug 21

Thursday's Top 20 US Stock Transactions: Micron Rises 3.97% Following $10 Billion Research Lab Announcement

Deep News
·
Aug 21

Thermo Fisher CHRO Lisa P. Britt Disposes of 11,440 Common Shares Worth $7.01 Million

Reuters
·
Aug 21

Moderna is up 350% Since Our Recommendation. Here's What to Do Next.

Dow Jones
·
Aug 21

Sector Update: Healthcare Stocks Fall Thursday Afternoon

MT Newswires Live
·
Aug 21

Congo Set to Receive 70,000 Ervebo Vaccines to Contain Ebola Outbreak, WHO Says

Reuters
·
Aug 21

Gavi Announces $7 Mln Funding for Shipment of 70,000 Doses of Ervebo Vaccine to DRC

Reuters
·
Aug 21

Merck Stock (MRK) Is a Strong Buy Now as 3 Top Wall Street Analysts Hike Price Targets

TIPRANKS
·
Aug 21

Eli Lilly Advances Early-Stage Eloralintide Trial: What Investors Should Watch

TIPRANKS
·
Aug 21

Eli Lilly’s Lebrikizumab Trial Completion Signals New Growth Path in Atopic Dermatitis

TIPRANKS
·
Aug 21